These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9632035)

  • 21. Nortriptyline for treatment-resistant depression.
    Nierenberg AA; Papakostas GI; Petersen T; Kelly KE; Iacoviello BM; Worthington JJ; Tedlow J; Alpert JE; Fava M
    J Clin Psychiatry; 2003 Jan; 64(1):35-9. PubMed ID: 12590621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
    Whyte EM; Basinski J; Farhi P; Dew MA; Begley A; Mulsant BH; Reynolds CF
    J Clin Psychiatry; 2004 Dec; 65(12):1634-41. PubMed ID: 15641868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.
    Szegedi A; Müller MJ; Anghelescu I; Klawe C; Kohnen R; Benkert O
    J Clin Psychiatry; 2003 Apr; 64(4):413-20. PubMed ID: 12716243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Care of depressed patients with anxiety symptoms.
    Nutt DJ
    J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
    Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
    J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.
    Keller MB; Ryan ND; Strober M; Klein RG; Kutcher SP; Birmaher B; Hagino OR; Koplewicz H; Carlson GA; Clarke GN; Emslie GJ; Feinberg D; Geller B; Kusumakar V; Papatheodorou G; Sack WH; Sweeney M; Wagner KD; Weller EB; Winters NC; Oakes R; McCafferty JP
    J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):762-72. PubMed ID: 11437014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.
    Rosenthal M
    J Clin Psychiatry; 2003 Oct; 64(10):1245-9. PubMed ID: 14658975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of nortriptyline and paroxetine on postural sway in depressed elderly patients.
    Mamo DC; Pollock BG; Mulsant B; Houck PR; Bensasi S; Miller MC; Redfern MS; Reynolds III CF
    Am J Geriatr Psychiatry; 2002; 10(2):199-205. PubMed ID: 11925281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight change in older depressed patients during acute pharmacotherapy with paroxetine and nortriptyline: a double-blind randomized trial.
    Weber E; Stack J; Pollock BG; Mulsant B; Begley A; Mazumdar S; Reynolds CF3rd
    Am J Geriatr Psychiatry; 2000; 8(3):245-50. PubMed ID: 10910424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slow versus standard up-titration of paroxetine for the treatment of depression in cancer patients: a pilot study.
    Amodeo L; Castelli L; Leombruni P; Cipriani D; Biancofiore A; Torta R
    Support Care Cancer; 2012 Feb; 20(2):375-84. PubMed ID: 21404089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melancholia with onset during treatment with SSRIs.
    Swartz CM; Guadagno G
    Ann Clin Psychiatry; 1998 Dec; 10(4):177-9. PubMed ID: 9988059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential benefits of slow titration of paroxetine treatment in an elderly population: eight-week results from a naturalistic setting.
    Gibiino S; Mori E; De Ronchi D; Serretti A
    J Clin Psychopharmacol; 2013 Aug; 33(4):565-9. PubMed ID: 23764690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients.
    Laghrissi-Thode F; Pollock BG; Miller MC; Mulsant BH; Altieri L; Finkel MS
    Psychopharmacol Bull; 1995; 31(4):659-63. PubMed ID: 8851637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up.
    Narushima K; Kosier JT; Robinson RG
    J Nerv Ment Dis; 2002 May; 190(5):296-303. PubMed ID: 12011609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.
    Mulsant BH; Sweet RA; Rosen J; Pollock BG; Zubenko GS; Flynn T; Begley AE; Mazumdar S; Reynolds CF
    J Clin Psychiatry; 2001 Aug; 62(8):597-604. PubMed ID: 11561930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerating antidepressant response in geriatric depression: a post hoc comparison of combined sleep deprivation and paroxetine versus monotherapy with paroxetine, nortriptyline, or placebo.
    Green TD; Reynolds CF; Mulsant BH; Pollock BG; Miller MD; Houck PR; Mazumdar S; Dew MA; Kupfer DJ
    J Geriatr Psychiatry Neurol; 1999; 12(2):67-71. PubMed ID: 10483927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
    Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
    J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Good treatment outcomes in late-life depression with comorbid anxiety.
    Lenze EJ; Mulsant BH; Dew MA; Shear MK; Houck P; Pollock BG; Reynolds CF
    J Affect Disord; 2003 Dec; 77(3):247-54. PubMed ID: 14612224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials.
    Kimura M; Tateno A; Robinson RG
    Am J Geriatr Psychiatry; 2003; 11(3):320-7. PubMed ID: 12724111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remission rates in patients with anxiety disorders treated with paroxetine.
    Ballenger JC
    J Clin Psychiatry; 2004 Dec; 65(12):1696-707. PubMed ID: 15641876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.